CellaVision receives the first Canadian orders for the new body fluid application

CellaVision AB (publ), which develops and sells digital morphology
products for the routine analysis of blood and other body fluids, has
received its first orders for the recently launched product,
CellaVision® Body Fluid Application from Canada. The customers are
all large hospital laboratories in the provinces of Ontario, British
Columbia and Nova Scotia."It is strategically important  for us to be  entrusted to deliver  a
new product this  soon after  its introduction to  the market,"  says
Yvonne Mårtensson, CEO of CellaVision. "This is an example of a newly
developed application which can be offered to potential and  existing
customers. In the long run it will give us recurring revenues."

The official  approval for  marketing  and selling  CellaVision  Body
Fluid Application was authorized by Canada Health in August 2008.

CellaVision has installed CellaVision® DM96 instruments mainly in
Europe and North America, and now has an accessible market for the
body fluid application. The performance of Body Fluids is a difficult
procedure in the clinical laboratory, and as such the efficiency and
quality benefits that CellaVision's technology delivers, makes this
an attractive offering for them.


Fore more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 708-33 77 82. E-mail: yvonne.martensson@cellavision.com


About CellaVision
CellaVision AB develops, markets, and sells the market leading  image
analysis based systems for routine  analysis of blood and other  body
fluids. The company has a core competence in development of  software
and hardware for automatic image  analysis of cells and cell  changes
for applications in health and medical care. The company develops and
markets systems for automatic differentials of white blood cells  and
red morphology, and software for  education and quality assurance  of
differentials. The company's  associates have  expertise in  advanced
imaging analysis, artificial intelligence, and automated microscopy.

The company headquarters are  in Lund, Sweden.  The company also  has
subsidiaries in  Jupiter,  Fl,  USA, Toronto,  Canada  and  Yokohama,
Japan. For more information, visit www.cellavision.com.

CellaVision's share is  listed on  First North at  the OMX  Stockholm
Stock Exchange. The company's Certified Advisor is Remium AB.